Surprisingly, HK2 has been found to be dispensable for T cell based immunity (19) thus pitching HK2 as a putative differential target in tumor cells that heavily rely on HK2 for their energy and biosynthetic demands (20). This evidence concerns the gene HK2 and neoplasm.